| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/20/2007 | US20070219240 N,N-Dimethyl-1-{4-[(2-phenyl-1H-benzimidazol-1-yl)methyl]-benzoyl}pyrrolidin-3-ylamine; cognition activator; neurodegenerative, developmental, sleep, eating disorders |
| 09/20/2007 | US20070219239 Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents |
| 09/20/2007 | US20070219237 Chromane Derivatives |
| 09/20/2007 | US20070219236 Dialkoxy-Imidazopyridines Derivatives |
| 09/20/2007 | US20070219235 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors |
| 09/20/2007 | US20070219234 Thienopyridine Derivatives |
| 09/20/2007 | US20070219233 Substituted Indoles and Their Use as Integrin Antagonists |
| 09/20/2007 | US20070219232 Chemical Compounds |
| 09/20/2007 | US20070219231 Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof |
| 09/20/2007 | US20070219230 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
| 09/20/2007 | US20070219229 Pyrrolopyridine Derivatives |
| 09/20/2007 | US20070219228 Aryl substituted imidazonaphthyridines |
| 09/20/2007 | US20070219227 Prodrugs of benzoquinolizine-2-carboxylic acid |
| 09/20/2007 | US20070219226 Methods for treating sarcopenia with a growth hormone secretagogue |
| 09/20/2007 | US20070219225 Pharmaceutical Compositions For The Prevention And Treatment Of Atherosclerosis |
| 09/20/2007 | US20070219224 Compositions and Methods Relating to Pyrimidine Synthesis Inhibitors |
| 09/20/2007 | US20070219223 Compositions and methods for treating respiratory disorders |
| 09/20/2007 | US20070219222 Inhibit Transient Receptor Potential A1 (TRPA1) activity ; incontinence |
| 09/20/2007 | US20070219221 administration of therapeutically effective amount of 3-ethyl-1-propyl-8-(1-{[3-(trifluoromethyl)phenyl]methyl}pyrazol-4-yl)-1,3,7-trihydropurine-2,6-dione, wherein hepatic disease is selected from necrosis, fibrosis, cholestasis, cirrhosis, viral and alcoholic hepatitis, ingestion of hepatotoxic drugs |
| 09/20/2007 | US20070219220 Pyrazolopyrimidinethione Derivatives, Salts and Solvates Thereof, Preparation Methods and Use Thereof |
| 09/20/2007 | US20070219219 Methods of Preparation and Resolution of E/Z Isomers of Vinylfuro[2,3-D]Pyrimidine and their Biological Activities and related compositions and methods of treatment |
| 09/20/2007 | US20070219218 Compounds for the treatment of inflammatory disorders |
| 09/20/2007 | US20070219217 Triazolone Derivatives as Mmp Inhibitors for the Treatment of Asthma and Copd |
| 09/20/2007 | US20070219216 1-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor Antagonists |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | US20070219214 Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation |
| 09/20/2007 | US20070219213 Use of Adrenergic N-Phenylpiperazine Antagonists, Pahrmaceutical Compositions Containning Them, and Methods of Preparing Them |
| 09/20/2007 | US20070219212 Pyranouidole Derivatives and the Use Thereof for the Treatment of Hepatitis C Virus Infection or Disease |
| 09/20/2007 | US20070219211 Such as 6-[4-(5-Fluoro-2-trifluoromethylbenzoyl)piperazin-1-yl]imidazo[1,2-b]pyridazine-2-carboxylic acid (3-methylbutyl)amide; for diseases related to elevated lipid/cholesterol levels, cardiovascular disease, diabetes, obesity, and metabolic syndrome |
| 09/20/2007 | US20070219210 Amidopyrazole Derivative |
| 09/20/2007 | US20070219209 Piperazine Derivatives Of Alkyl Oxindoles |
| 09/20/2007 | US20070219208 Methods for Treating Cancer |
| 09/20/2007 | US20070219207 E.g. (2-isobutoxy-5-methanesulfonyl-phenyl)-(4-quinolin-2-yl-piperazin-1-yl)-methanone; glycine transporter 1 (GlyT-1) inhibitor, increasing activation of NMDA receptors; cognition activator; schizophrenia, psychoses, attention deficit disorders or Alzheimer's disease |
| 09/20/2007 | US20070219206 5-lipoxygenase-activating protein (flap) inhibitors |
| 09/20/2007 | US20070219205 To treat autoimmune, inflammatory, proliferative, hyperproliferative,neurodegenerative or immunologically-mediated diseases; useful for the study of kinases in biological and pathological phenomena; study of intracellular signal transduction pathways mediated by such kinases, and comparative evaluation |
| 09/20/2007 | US20070219204 Pharmaceutically active ornitihine derivatives, ammonium salts thereof and methods of making same |
| 09/20/2007 | US20070219203 Arylalkylamino-substituted quinazoline analogues |
| 09/20/2007 | US20070219202 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 09/20/2007 | US20070219201 Combination of atomoxetine and a 5ht1a receptor agonist for treating adhd and other disorders |
| 09/20/2007 | US20070219200 Prodrugs of heteroaryl compounds |
| 09/20/2007 | US20070219198 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) for treatment of Type 2 diabetes, syndrome X, dyslipidemias, atherosclerosis, Alzheimer's and as wound healing agents; (2R)-1,1,1-trifluoro-2-[3-({(2R)-4-[4-fluoro-2-(trifluoromethyl)phenyl]-2-methylpiperazin-1-yl}sulfonyl)phenyl]propan-2-ol for example |
| 09/20/2007 | US20070219197 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives |
| 09/20/2007 | US20070219196 Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| 09/20/2007 | US20070219195 e.g. 4-(5-Methyl-2H-pyrazole-3-ylamino)-phenyl-2H-phthalazin-1-one2-Phenyl-2,3-dihydro-phthalazine-1,4-dione; tyrosine kinase inhibitor; antiinflammatory agent; asthma, rheumatoid arthritis, systemic lupus erythematosus or multiple sclerosis |
| 09/20/2007 | US20070219194 Phenylalanine derivatives |
| 09/20/2007 | US20070219193 Alkylamine-substituted bicyclic aryl compounds useful as modulators of ppar |
| 09/20/2007 | US20070219192 Certain chemical entities, compositions, and methods |
| 09/20/2007 | US20070219191 3-Pyridinium Methyl Cephem Compound |
| 09/20/2007 | US20070219190 Heterocyclic NF-kB Inhibitors |
| 09/20/2007 | US20070219189 Mif-inhibitors |
| 09/20/2007 | US20070219188 Oxadiazine Derivatives |
| 09/20/2007 | US20070219187 Allosteric Modulators of Metabotropic Glutamate Receptors |
| 09/20/2007 | US20070219186 Pyrazolo[1,5-A]pyrimidine derivatives and methods of use thereof |
| 09/20/2007 | US20070219185 Preventive or therapeutic agent for neuropathic pain |
| 09/20/2007 | US20070219184 Method of increasing thymic output in HIV-negative patients by treatment with antiretroviral agents |
| 09/20/2007 | US20070219183 Dihydropyrazolo[1,5-A]pyrimidine and dihydroimidazo[1,5-A]pyrimidine derivatives and methods of use thereof |
| 09/20/2007 | US20070219182 1H-2-Benzazepine-1,5(2H)-dione derivatives in which the N is connected via alkylene to a saturated or monounsaterated nitrogen heterocycle, e.g.,2-(3-{4-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl}propyl)-3,4-dihydro-1H-2-benzazepine-1,5(2H)-dione; dopamine-3 receptor modulators |
| 09/20/2007 | US20070219181 1-(4-fluorophenyl)-3-{(E)-2-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]vinyl}-6,7-dihydro-5H-imidazo-[1,5-a]pyrazin-8-one; for diseases caused by amyloid- beta is Alzheimer's disease, dementia, Down's syndrome or amyloidosis |
| 09/20/2007 | US20070219180 Muscle Relaxtion Accelerator and Therapeutic Agent for Muscular Tissue Diseases Such as Muscle Relaxation Failure |
| 09/20/2007 | US20070219179 Indole Derivative Having Piperidine Ring |
| 09/20/2007 | US20070219178 Preventive or therapeutic agents for multiple sclerosis |
| 09/20/2007 | US20070219177 Agent for treatment of cerebral ischemic diseases |
| 09/20/2007 | US20070219176 Viral Polymerase Inhibitors |
| 09/20/2007 | US20070219175 Controlled Release Pharmaceutical Composition Comprising An Acid-Insoluble And A Bioadhesive Polymer |
| 09/20/2007 | US20070219174 Methods of treating cancer using hypofractionated radiation and texaphyrins |
| 09/20/2007 | US20070219173 Ligands for nematode nuclear receptors and uses thereof |
| 09/20/2007 | US20070219172 Selective testicular 11beta-HSD inhibitors for the treatment of hypergonadism associated disorders and modulation of fertility |
| 09/20/2007 | US20070219171 Transdermal Pharmaceutical Spray Formulations Comprising a Vp/Va Copolymer and a Non-Aquous Vehicle |
| 09/20/2007 | US20070219170 Ophthalmic compositions comprising povidone-iodine |
| 09/20/2007 | US20070219169 Pharmaceutical compositions comprising trimegestone |
| 09/20/2007 | US20070219168 19,26,27-TRINOR-1alpha,25-DIHYDROXYVITAMIN D3 COMPOUNDS |
| 09/20/2007 | US20070219167 Composition and method of treating hearing loss |
| 09/20/2007 | US20070219166 Stereoselective Method for the Production of Clopidogrel |
| 09/20/2007 | US20070219165 Peptidomimetic Inhibitors Of PSMA, Compounds Comprising Them, And Methods of Use |
| 09/20/2007 | US20070219164 myo-inositol ester prodrugs of valproic acid, such as 1,2,3,4,5,6-hexa-O-(2-propylpentanoyl)-myo-inositol, used for treating headaches, bipolar and nervous system disorders, and as antiepileptic agents |
| 09/20/2007 | US20070219163 2-amino-2-[5-(4-octyl-phenyl)-1H-imidazol-2-yl]-propan-1-ol or phosphate, sphingosine-1-phosphate (S1P) receptor modulators; agonists; antagonists; G protein coupled receptors; cell proliferation endothelial cells chemotaxis; antitumor agents; wound healing agents;platelet aggregation |
| 09/20/2007 | US20070219162 Partially-fluorinated ethers, compositions and uses thereof, for long-term tamponade in the eye |
| 09/20/2007 | US20070219160 Process Tolerant Starch Composition with High Total Dietary Fiber Content |
| 09/20/2007 | US20070219159 Cyclodextrin compositions and methods of treating viral infections |
| 09/20/2007 | US20070219157 Complete nutrient medium for use as a cosmetic and cosmetic use thereof |
| 09/20/2007 | US20070219156 Method of treatment for central nervous system injury |
| 09/20/2007 | US20070219155 Treating trinucleotide repeat conditions |
| 09/20/2007 | US20070219154 Methods for preventing and/or treating a cell proliferative disorder |
| 09/20/2007 | US20070219152 Inhibition of Syk kinase expression |
| 09/20/2007 | US20070219151 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 09/20/2007 | US20070219150 Nerve Cell Differentiation Inducer |
| 09/20/2007 | US20070219148 Small Interfering RNA Specific to Sub-Units $g(a),$g(a)' and $g(b) of the Kinase Protein ck2,and the Applications of the Same |
| 09/20/2007 | US20070219146 Synergistic Pharmaceutical And/Or Neutraceutical Flavanoid Composition For Management Of Diabetes Mellitus |
| 09/20/2007 | US20070219145 Radiosensitizer |
| 09/20/2007 | US20070219144 Immunomodulatory saccharide compounds |
| 09/20/2007 | US20070219143 Antiinflammatory Lactones |
| 09/20/2007 | US20070219142 Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the Eye |
| 09/20/2007 | US20070219141 Plant Materials Extraction Method |
| 09/20/2007 | US20070219140 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents |
| 09/20/2007 | US20070219131 Compositions capable of facilitating penetration across a biological barrier |
| 09/20/2007 | US20070219120 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 09/20/2007 | US20070219118 Therapeutic methods for nucleic acid delivery vehicles |
| 09/20/2007 | US20070219115 Pharmaceutical Uses of Bisphosphonates |
| 09/20/2007 | US20070219114 Preventives or Remedies for Hepatopathy |
| 09/20/2007 | US20070218491 Oligomerization of amyloid proteins |